Today is June 17, 2024. All times in Eastern Daylight Time.
Celltrion présente à EULAR 2024 les résultats prometteurs d’une étude de phase III sur le CT-P47, un candidat biosimilaire de RoActemra® (tocilizumab), menée sur des patients atteints de polyarthrite rhumatoïde (PR)
06/16/2024 - 08:14 PM
BUSINESS WIRE
Celltrion presenta risultati promettenti all'EULAR 2024 nello studio di fase III per CT-P47, candidato biosimilare di RoActemra® (tocilizumab) in pazienti affetti da artrite reumatoide (AR)
06/16/2024 - 08:13 PM
BUSINESS WIRE
Mirum Pharmaceuticals to Host Investor Call to Share Interim Analysis Results from the Volixibat VANTAGE and VISTAS studies on June 17, 2024
06/16/2024 - 05:00 PM
BUSINESS WIRE
Juicy Stakes Casino Still the Daddy
06/16/2024 - 03:57 PM
BUSINESS WIRE
A Spectacle in NYC: Empire State Building Debuts 270-Foot Vhagar the Dragon Coiled Around the Building’s Mast, in Partnership with Max
06/16/2024 - 02:41 PM
BUSINESS WIRE
RBLX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Roblox Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
06/16/2024 - 10:05 AM
BUSINESS WIRE
BreachBits Announces Agreement Between SentryMark and Nippon Telematique for Distribution of BreachRisk™ Solutions in Japan
06/16/2024 - 08:00 AM
BUSINESS WIRE
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of disease progression or death by 27% vs. standard of care in patients with untreated mantle cell lymphoma in ECHO Phase III trial
06/16/2024 - 07:00 AM
BUSINESS WIRE
Igloo Coolers präsentiert seine Produkte zur aktiven Kühlung auf der Spoga+Gafa
06/16/2024 - 05:44 AM
BUSINESS WIRE
CORRECTING and REPLACING Liby Master Fragrance from China Unlocks Premium Fragrance Market in Grasse
06/16/2024 - 05:32 AM
BUSINESS WIRE
1
2
3
4
5
6
7
8
9
10
11
...
1341
« Previous
Next »